Reply by Authors

. 2023 Aug;210(2):310-311.

doi: 10.1097/JU.0000000000003493.02. Epub 2023 Jul 7.

Affiliations

¹ Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.
² Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
³ Department of Medical Oncology, Montefiore Medical Center, Bronx, New York.
⁴ Division of Nuclear Medicine, Mallinckrodt Institute of Radiology and the Alvin J. Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri.
⁵ Department of Genitourinary Oncology, John Wayne Cancer Institute, Santa Monica, California.
⁶ Urology San Antonio, San Antonio, Texas.
⁷ Virginia Oncology Associates, US Oncology Research, Norfolk, Virginia.
⁸ Blue Earth Diagnostics Ltd, Oxford, United Kingdom.
⁹ Blue Earth Diagnostics Inc, Monroe Township, New Jersey.
¹⁰ Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
¹¹ Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia.

Ashesh B Jani et al. J Urol. 2023 Aug.

. 2023 Aug;210(2):310-311.

doi: 10.1097/JU.0000000000003493.02. Epub 2023 Jul 7.

¹ Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.
² Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
³ Department of Medical Oncology, Montefiore Medical Center, Bronx, New York.
⁴ Division of Nuclear Medicine, Mallinckrodt Institute of Radiology and the Alvin J. Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri.
⁵ Department of Genitourinary Oncology, John Wayne Cancer Institute, Santa Monica, California.
⁶ Urology San Antonio, San Antonio, Texas.
⁷ Virginia Oncology Associates, US Oncology Research, Norfolk, Virginia.
⁸ Blue Earth Diagnostics Ltd, Oxford, United Kingdom.
⁹ Blue Earth Diagnostics Inc, Monroe Township, New Jersey.
¹⁰ Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
¹¹ Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia.

No abstract available

Cited by

Flotufolastat F 18: Diagnostic First Approval.
Heo YA. Heo YA. Mol Diagn Ther. 2023 Sep;27(5):631-636. doi: 10.1007/s40291-023-00665-y. Epub 2023 Jul 13. Mol Diagn Ther. 2023. PMID: 37439946 Review.